Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 936 results for "aurobindo"

2 arrested for bid to kidnap woman

New Delhi, Sep 30 (PTI) Two men who allegedly tried to kidnap a working woman from Aurobindo Marg near AIIMS in South Delhi last evening have been arrested. The two accused, identified as Sandeep Yadav (26) and Babloo Sharma (22), both residents of ... Press Trust of India, 21 hours ago
Two arrested for bid to kidnap woman in Delhi ZeeNews.com, 20 hours ago

54 images for aurobindo

Money Today, 6 days ago
Business Standard India, 1 week ago
Livemint.com, 1 week ago
LSI Online, 1 week ago
Bangladesh Daily Star, 3 weeks ago
India Education Diary.in, 1 month ago
indianexpress.com, 1 month ago
Bio Spectrum Asia, 1 month ago
Rediff.com, 2 months ago
Rediff.com, 2 months ago

Buy Aurobindo Pharma with a target of Rs 960: Mitesh Thacker

In a chat with ET Now, Mitesh Thacker, Technical Analyst, miteshthacker.com, shares his views on Aurobindo Pharma. ET Now: What is your call on Aurobindo Pharma? Mitesh Thacker: Aurobindo Pharma is a 'BUY' call with a target of Rs 960 and a stop ...
 Economic Times2 days ago Sell Aurobindo Pharma Ltd with a stop loss of Rs 838: Sandeep Wagle  Economic Times1 week ago Sell Aurobindo Pharma with a stop loss of Rs 851: Mitesh Thacker  Economic Times1 week ago Super Six stocks that should do well today  Money Control3 weeks ago
[x]  
Business Standard

Aurobindo Pharma firms up on pact with MPP for HIV drug

Email this Print Shares of Aurobindo Pharma were up over 1% after it was one of the Indian pharma companies to sign an agreement with Medicines Patent Pool. The Medicines Patent Pool announced six new sub-licences with Aurobindo Pharma, Cipla, ...
 Business Standard India5 days ago Aurobindo Pharma trades jubilantly on the bourses  Arihant Capital6 days ago DRL, Aurobindo Dragged to US Court Over Patents  New Indian Express1 week ago Stocks to watch out on Monday  Moneycontrol.com1 week ago
[x]  
Business Standard

Indian drug makers in UN patents pool

The UN-backed Medicines Patents Pool has signed six sub-licences with Aurobindo, Cipla, Desano, Emcure, Hetero Labs and Laurus Labs, allowing them to make generic anti-AIDS medicine Tenofovir Alafenamide (TAF) for 112 developing countries. TAF is ...
 Hindu Business Line4 days ago Medicines Patent Pool signs six new sub-licenses for HIV treatment tenofovir alafenamide  Pharma Letter5 days ago Medicines Patent Pool signs deal with 5 Indian companies for HIV drug  Business Standard5 days ago Cipla, Mylan, Micro Labs, Aurobindo, Emcure ink licensing pact for antiretrovirals with a UN unit  Business Standard2 months ago

Bull's Eye: Buy Biocon, India Cements, Aurobindo Pharma

Vishal Malkan, malkansview.com advises buying India Cements for a target price of Rs 138 and Aurobindo Pharma for a target price of Rs 900.
 Money Control1 week ago Bull's Eye: JP Associates, Tech Mahindra, Aurobindo Pharma  Money Control1 month ago Buy LIC Housing, Tata Comm, Aurobindo Pharma: Manav Chopra  Money Control1 month ago Bull's Eye: Buy Aurobindo, Adani Enterprises; short IFCI  Money Control1 month ago
Money Control

Here are top 10 stocks to keep an eye on Sep 26

Here are top 10 stocks to keep an eye on Sep 26 - Bharti Airtel, GMR Infra, Aurobindo Pharma, Cipla, JP Associates, JP Power, JSW Energy, Petronet LNG, Hindalco and Sun Pharma.
 Money Control5 days ago PLilladher sees Nifty at 8200 soon; picks top 4 bets  Moneycontrol.com1 month ago Here are top 10 stocks to watch on August 8  Money Control1 month ago
Business Standard

Aurobindo: Long-term benefits outweigh near-term challenges

Related to : Aurobindo Pharma Ltd Aurobindo Pharma Ltd BSE 23 Sep 14 | 01:47 PM 836.55 -16.85 (-1.97%) NSE 23 Sep 14 | 01:35 PM 839.35 -13.05 (-1.53%) The share price of Hyderabad-based Aurobindo Pharma has zoomed from Rs 180 ...
 Business Standard India1 week ago Aurobindo Pharma aims $2 bn revenues in FY15  Business Standard1 month ago Makers of oriental literature  Sri Lanka Daily News1 month ago
Sify

Sensex, Nifty fall 1%, Aurobindo Pharma rises

The Sensex on Thursday closed 276 points or 1.03 per cent lower amid monthly expiry in derivatives segment. Nifty too fell 1.13 per cent or 90.55 points to 7,911.85 points. Reliance Industries and ONGC fell 3.23 per cent and 2.61 per cent, ...
 Business Today India6 days ago Market ends flat; Nifty ends below 8,000 mark  Business Standard India1 day ago Sensex trades 50 points lower; Sun Pharma, Axis Bank fall [Mint, New Delhi :: ]  BusinessWeek5 days ago Sensex rangebound; pharma, power, auto gain  Economic Times1 week ago

Lupin, Aurobindo and Mylan bags outstanding exports awards for 2013-14

Lupin, Aurobindo and Mylan, have bagged Pharmexcil's top export awards for their outstanding export performances in the bulk drugs and formulations category for the year 2013-14. Out of more than 150 applications in exports category, Mumbai based ...
 PharmaBiz6 days ago Pharmexcil announces outstanding exports awards  Bio Spectrum Asia6 days ago

Reckitt files patent infringement case against Aurobindo Pharma

Summary New Jersey-based Reckitt Benckiser LLC has filed a patent infringement case against Aurobindo Pharma. New Jersey-based Reckitt Benckiser LLC has filed a patent infringement case against Aurobindo Pharma. The infringement ...
 Financial Express1 week ago INDIA PRESS-Reckitt files patent infringement case against Aurobindo Pharma - Financial Express  Reuters UK1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less